Study analysis · Cell metabolism · 2019
They lost weight and lowered blood pressure—without dieting, exercising, or changing meds.
People with metabolic syndrome lost weight, lowered cholesterol, and improved blood sugar just by eating all their food within a 10-hour window each day.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study watched 19 people eat within a 10-hour window for 12 weeks and noticed they lost a little weight and their blood pressure improved. But since no one else was compared to them, we don’t know if the eating schedule caused the changes — maybe they just happened to eat better or move more without realizing it.
What’s the bottom line?
People with metabolic syndrome ate all their food within a 10-hour window each day for 12 weeks, without changing what they ate or how much they moved.
How strong is this study?
This study tried hard to track what people ate and how they slept, which is good. But it didn’t have a group of people who didn’t change their eating habits to compare against, so we can’t be sure the results are real. It’s like saying your plant grew taller after you talked to it — but you didn’t check if other plants grew too.
35 / 100
- COI disclosureconflicts of interest not disclosed
- Data availability+35/35
- Code availabilitycode not shared
15 / 100
- Randomizationnot randomized
- Blindingnot blinded
- Control groupno control group
- Sample size (n=19)+1.8/20
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 546 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is a single-arm, unblinded, non-randomized cohort study with no control group, so observed changes cannot be confidently attributed to the intervention alone. Confounding factors such as natural variation, placebo effects, or unmeasured lifestyle changes cannot be ruled out.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the text; study appears independently conducted.
The study was conducted at UC San Diego and The Salk Institute, with IRB approval and informed consent, but no funding sources, author affiliations with industry, or conflicts of interest were disclosed. No evidence of industry influence or funder involvement was found.
Key takeaways
- 01
They lost 3.3 kg (3%), their waist got 4.5 cm smaller, blood pressure dropped by 5-6 mmHg, bad cholesterol (LDL) fell by 11%, and blood sugar (HbA1c) improved by 0.22% in those with high sugar levels.
- 02
These changes are similar to what you’d see with medication or major diet changes — and happened without trying to eat less or exercise more.
Surprising findings
- Caloric intake dropped by 8.6% without any instruction to eat less.Most TRE studies assume weight loss comes from reduced calories—but here, participants weren’t told to eat less, yet they naturally ate less, suggesting timing regulates appetite.
- Sleep quality improved significantly—even though total sleep time didn’t change.People reported feeling 23% more restful in the mornings, despite no increase in sleep duration, hinting that timing improves sleep quality, not just quantity.
- No adverse effects were reported despite 12 weeks of restricted eating.Many fear fasting causes fatigue, headaches, or hunger—but in this high-risk group on multiple meds, not a single adverse event was recorded.
Practical takeaways
Try confining all eating to a 10-hour window each day—e.g., 8 a.m. to 6 p.m.—without changing your food or activity.
This was studied in adults with metabolic syndrome on meds; results may not apply to children, pregnant women, or those with eating disorders.
medium confidenceUse a free app like myCircadianClock to track your eating window and notice if you feel more energized or sleep better.
Calorie intake dropped naturally here—don’t assume you’ll lose weight if you’re already at a healthy weight.
medium confidenceIf you’re on blood pressure or cholesterol meds, talk to your doctor about adding TRE as a complementary strategy.
Never stop or adjust meds without medical supervision—even if you feel better.
low confidenceWhy this study matters
No Dieting, No Exercise—Just Timing
In a 12-week trial with 19 adults with metabolic syndrome, participants lost an average of 3.3 kg (3%) and reduced waist circumference by 4.5 cm—without changing what they ate or how much they moved. They simply confined eating to a self-chosen 10-hour window daily.
This challenges the belief that weight loss and metabolic improvement require calorie restriction or physical activity—suggesting timing alone can drive health gains.
Blood Pressure Drop Without Med Changes
Systolic blood pressure dropped by 5.1 mmHg and diastolic by 6.5 mmHg—even though 63% of participants were already on antihypertensive medications. These improvements were independent of weight loss.
This suggests TRE could be a powerful add-on therapy for people already on meds, potentially reducing pill burden or improving control.
HbA1c Improved in High-Risk Group
Among the 12 participants with elevated baseline HbA1c (≥5.7%), levels dropped by 0.22% (3.7%)—a clinically meaningful change. One participant with T2DM (HbA1c 6.5%) saw it fall to 5.5%.
This shows TRE may be especially beneficial for those with prediabetes or early diabetes—not just healthy people.
Cholesterol Fell 11%—Without Statin Adjustments
LDL cholesterol dropped by 11.9 mg/dL (11%) and non-HDL-C by 9%—despite 79% of participants already taking statins. The drop was greater than expected for a 3% weight loss.
This implies TRE may enhance the effect of cholesterol meds, offering a free, non-pharmaceutical boost to heart health.
Meal Timing Became 40% More Consistent
The day-to-day variability in first and last meal times dropped by 40–44%—meaning people ate at much more predictable times, which may stabilize circadian metabolism.
Irregular eating is linked to metabolic disease; this study shows TRE naturally fixes that—no willpower needed.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
People with metabolic syndrome ate all their food within a 10-hour window each day for 12 weeks, without changing what they ate or how much they moved.
Research results
They lost 3.3 kg (3%), their waist got 4.5 cm smaller, blood pressure dropped by 5-6 mmHg, bad cholesterol (LDL) fell by 11%, and blood sugar (HbA1c) improved by 0.22% in those with high sugar levels.
What this means - more context
These changes are similar to what you’d see with medication or major diet changes — and happened without trying to eat less or exercise more.
This study investigates whether a 10-hour time-restricted eating (TRE) window improves cardiometabolic health in adults with metabolic syndrome who are already on standard medical care.
In a 12-week single-arm trial with 19 participants, a self-selected 10-hour TRE window led to significant reductions in weight, waist circumference, body fat, blood pressure, LDL-C, and non-HDL-C, independent of weight loss. HbA1c improved significantly in those with elevated baseline glucose. No adverse effects were reported, and adherence was high despite no dietary or activity changes.
Methods Used
Single-arm, non-randomized, prospective intervention in 19 adults with metabolic syndrome (mean age 59, 84% on statins/antihypertensives). Participants used a smartphone app (myCircadianClock) to self-select and log a 10-hour daily eating window for 12 weeks without dietary or activity modifications. Outcomes were measured via bioimpedance, CGM, actigraphy, and fasting blood tests.
Main Finding
A 12-week 10-hour TRE intervention resulted in a mean weight loss of 3.3 kg (3%), waist circumference reduction of 4.5 cm (4%), systolic BP reduction of 5.1 mmHg, diastolic BP reduction of 6.5 mmHg, LDL-C reduction of 11.9 mg/dL (11%), and non-HDL-C reduction of 11.6 mg/dL (9%), all independent of weight loss. HbA1c decreased by 0.22% (3.7%) in participants with elevated baseline glucose.
Confidence Level
Low to moderate; findings are from a small, unblinded, single-arm pilot study without a control group, though effect sizes are clinically meaningful and consistent across multiple outcomes.
Study Flags
Red Flags
- •No control group
- •Small sample size (n=19)
- •Self-reported dietary data with potential for underreporting
Surprising Findings
Caloric intake dropped by 8.6% without any instruction to eat less.
Most TRE studies assume weight loss comes from reduced calories—but here, participants weren’t told to eat less, yet they naturally ate less, suggesting timing regulates appetite.
Practical Takeaways
Try confining all eating to a 10-hour window each day—e.g., 8 a.m. to 6 p.m.—without changing your food or activity.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 546 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study watched 19 people eat within a 10-hour window for 12 weeks and noticed they lost a little weight and their blood pressure improved. But since no one else was compared to them, we don’t know if the eating schedule caused the changes — maybe they just happened to eat better or move more without realizing it.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Used validated tools (mCC app, CGM, actigraphy) for real-time behavioral monitoring
- Long follow-up period (12 weeks) with high adherence (85.6%)
- Measured multiple clinically relevant outcomes (weight, BP, lipids, HbA1c)
Weaknesses
- No control group to compare against
- Not randomized or blinded
- Small sample size limits statistical power
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
People with metabolic syndrome ate all their food within a 10-hour window each day for 12 weeks, without changing what they ate or how much they moved.
Research results
They lost 3.3 kg (3%), their waist got 4.5 cm smaller, blood pressure dropped by 5-6 mmHg, bad cholesterol (LDL) fell by 11%, and blood sugar (HbA1c) improved by 0.22% in those with high sugar levels.
What this means - more context
These changes are similar to what you’d see with medication or major diet changes — and happened without trying to eat less or exercise more.
This study investigates whether a 10-hour time-restricted eating (TRE) window improves cardiometabolic health in adults with metabolic syndrome who are already on standard medical care.
In a 12-week single-arm trial with 19 participants, a self-selected 10-hour TRE window led to significant reductions in weight, waist circumference, body fat, blood pressure, LDL-C, and non-HDL-C, independent of weight loss. HbA1c improved significantly in those with elevated baseline glucose. No adverse effects were reported, and adherence was high despite no dietary or activity changes.
Methods Used
Single-arm, non-randomized, prospective intervention in 19 adults with metabolic syndrome (mean age 59, 84% on statins/antihypertensives). Participants used a smartphone app (myCircadianClock) to self-select and log a 10-hour daily eating window for 12 weeks without dietary or activity modifications. Outcomes were measured via bioimpedance, CGM, actigraphy, and fasting blood tests.
Main Finding
A 12-week 10-hour TRE intervention resulted in a mean weight loss of 3.3 kg (3%), waist circumference reduction of 4.5 cm (4%), systolic BP reduction of 5.1 mmHg, diastolic BP reduction of 6.5 mmHg, LDL-C reduction of 11.9 mg/dL (11%), and non-HDL-C reduction of 11.6 mg/dL (9%), all independent of weight loss. HbA1c decreased by 0.22% (3.7%) in participants with elevated baseline glucose.
Confidence Level
Low to moderate; findings are from a small, unblinded, single-arm pilot study without a control group, though effect sizes are clinically meaningful and consistent across multiple outcomes.
Study Flags
Red Flags
- •No control group
- •Small sample size (n=19)
- •Self-reported dietary data with potential for underreporting
Surprising Findings
Caloric intake dropped by 8.6% without any instruction to eat less.
Most TRE studies assume weight loss comes from reduced calories—but here, participants weren’t told to eat less, yet they naturally ate less, suggesting timing regulates appetite.
Practical Takeaways
Try confining all eating to a 10-hour window each day—e.g., 8 a.m. to 6 p.m.—without changing your food or activity.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 546 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study watched 19 people eat within a 10-hour window for 12 weeks and noticed they lost a little weight and their blood pressure improved. But since no one else was compared to them, we don’t know if the eating schedule caused the changes — maybe they just happened to eat better or move more without realizing it.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Used validated tools (mCC app, CGM, actigraphy) for real-time behavioral monitoring
- Long follow-up period (12 weeks) with high adherence (85.6%)
- Measured multiple clinically relevant outcomes (weight, BP, lipids, HbA1c)
Weaknesses
- No control group to compare against
- Not randomized or blinded
- Small sample size limits statistical power
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study tried hard to track what people ate and how they slept, which is good. But it didn’t have a group of people who didn’t change their eating habits to compare against, so we can’t be sure the results are real. It’s like saying your plant grew taller after you talked to it — but you didn’t check if other plants grew too.
35 / 100
- COI disclosureconflicts of interest not disclosed
- Data availability+35/35
- Code availabilitycode not shared
15 / 100
- Randomizationnot randomized
- Blindingnot blinded
- Control groupno control group
- Sample size (n=19)+1.8/20
- Follow-up+10/10
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 546 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is a single-arm, unblinded, non-randomized cohort study with no control group, so observed changes cannot be confidently attributed to the intervention alone. Confounding factors such as natural variation, placebo effects, or unmeasured lifestyle changes cannot be ruled out.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the text; study appears independently conducted.
The study was conducted at UC San Diego and The Salk Institute, with IRB approval and informed consent, but no funding sources, author affiliations with industry, or conflicts of interest were disclosed. No evidence of industry influence or funder involvement was found.